Indication-based pricing for Novartis’ CAR-T cell therapy Kymriah … – Business Insider
Business Insider |
Indication-based pricing for Novartis’ CAR-T cell therapy Kymriah …
Business Insider A cutting-edge new cancer treatment just got approved to treat more people with certain blood cancers last week. The second approval came with a different price. Controlling CAR-T: How scientists plan to make the engineered T …Chemical & Engineering News Kymriah Gets Expanded Approval for Large B-Cell LymphomaSPT Industry Guide |
Big Think (blog) |
Fasting For Just 24 Hours Boosts The Regeneration of Stem Cells, Study Finds
ScienceAlert In the study, that conversion didn’t just mean cells use up fat as an energy source instead of carbohydrates. Making the switch also enhanced their functioning. Intestinal stem cells, which the researchers describe as the “workhorses of the intestine … MIT study: 24-hour fasting regenerates stem cells, doubles metabolismBig Think (blog) |
Nasdaq |
FDA Grants Priority Review To Genentech’s Cancer Immunotherapy TECENTRIQ
Nasdaq (RTTNews.com) – Genentech, a member of the Roche Group ( RHHBY ), said that the U.S. Food and Drug Administration has accepted the company’s supplemental Biologics License Application or sBLA and granted Priority Review for TECENTRIQ or atezolizumab … FDA Grants Priority Review to Genentech’s Cancer Immunotherapy TECENTRIQ (Atezolizumab) for Initial Treatment of …Business Wire (press release) Roche’s Tecentriq combination to get speedy FDA reviewReuters |